TPIDB > Principal Investigator
Principal Investigator
National Taiwan University Hospital
(在職)
Division of Obstetrics & Gynecology
Division of General Internal Medicine
Division of Hematology & Oncology
更新時間：2023-09-19
鄭文芳Cheng, Wen-Fang
- Principal Investigator
- Clinical Trial Experience (year) 17 years 10 個月
Publication
21Publications
11
Chen YL, Lin HW, Chien CL, Lai YL, Sun WZ, Chen CA, Cheng WF. BTLA blockade enhances Cancer therapy by inhibiting IL-6/IL-10-induced CD19high B lymphocytes. J Immunother Cancer. 2019 Nov 21;7(1):313. doi: 10.1186/s40425-019-0744-4. PMID: 31753019; PMCID: PMC6868712.
12
Lu TP, Kuo KT, Chen CH, Chang MC, Lin HP, Hu YH, Chiang YC, Cheng WF, Chen CA. Developing a Prognostic Gene Panel of Epithelial Ovarian Cancer Patients by a Machine Learning Model. Cancers (Basel). 2019 Feb 25;11(2):270. doi: 10.3390/cancers11020270. PMID: 30823599; PMCID: PMC6406249.
13
Sun NY, Chen YL, Lin HW, Chiang YC, Chang CF, Tai YJ, Chen CA, Sun WZ, Chien CL, Cheng WF. Immune checkpoint Ab enhances the antigen-specific anti-tumor effects by modulating both dendritic cells and regulatory T lymphocytes. Cancer Lett. 2019 Mar 1;444:20-34. doi: 10.1016/j.canlet.2018.11.039. Epub 2018 Dec 10. PMID: 30543813.
14
Hsieh SF, Lau HY, Wu HH, Hsu HC, Twu NF, Cheng WF. Prognostic Factors of Early Stage Epithelial Ovarian Carcinoma. Int J Environ Res Public Health. 2019 Feb 21;16(4):637. doi: 10.3390/ijerph16040637. PMID: 30795566; PMCID: PMC6406698.
15
Chen YL, Lin HW, Sun NY, Yie JC, Hung HC, Chen CA, Sun WZ, Cheng WF. mTOR Inhibitors Can Enhance the Anti-Tumor Effects of DNA Vaccines through Modulating Dendritic Cell Function in the Tumor Microenvironment. Cancers (Basel). 2019 May 2;11(5):617. doi: 10.3390/cancers11050617. PMID: 31052575; PMCID: PMC6562783.
16
Tai YJ, Hsu HC, Chiang YC, Chen YL, Chen CA, Cheng WF. Impact of Adjuvant Modalities on Survival in Patients with Advanced Stage Endometrial Carcinoma: A Retrospective Analysis from a Tertiary Medical Center. Int J Environ Res Public Health. 2019 Jul 18;16(14):2561. doi: 10.3390/ijerph16142561. PMID: 31323767; PMCID: PMC6678420.
17
Lee SP, Hsu HC, Tai YJ, Chen YL, Chiang YC, Chen CA, Cheng WF. Bevacizumab Dose Affects the Severity of Adverse Events in Gynecologic Malignancies. Front Pharmacol. 2019 Apr 26;10:426. doi: 10.3389/fphar.2019.00426. PMID: 31105567; PMCID: PMC6498445.
18
Tang CH, Cheng WF, Jiang JH, You SL, Huang LW, Hsieh JY, Mukherjee P, Van Kriekinge G, Lee C. Cost-Effectiveness Analysis of Human Papillomavirus Vaccination in Adolescent Girls in Taiwan. Asian Pac J Cancer Prev. 2019 May 25;20(5):1377-1387. doi: 10.31557/APJCP.2019.20.5.1377. PMID: 31127896; PMCID: PMC6857899.
19
Lin HW, Chiang YC, Sun NY, Chen YL, Chang CF, Tai YJ, Chen CA, Cheng WF. CHI3L1 results in poor outcome of ovarian cancer by promoting properties of stem-like cells. Endocr Relat Cancer. 2019 Jan 1;26(1):73-88. doi: 10.1530/ERC-18-0300. PMID: 30121622.
20
Lai YL, Hsu HC, Kuo KT, Chen YL, Chen CA, Cheng WF. Clear Cell Carcinoma of the Abdominal Wall as a Rare Complication of General Obstetric and Gynecologic Surgeries: 15 Years of Experience at a Large Academic Institution. Int J Environ Res Public Health. 2019 Feb 14;16(4):552. doi: 10.3390/ijerph16040552. PMID: 30769847; PMCID: PMC6406533.
